Free Trial
OTCMKTS:GLUC

Glucose Health Q2 2026 Earnings Results & Report

Glucose Health logo
$0.34 -0.02 (-5.11%)
As of 01:24 PM Eastern

Glucose Health reported Q2 2026 earnings on August 14, 2026. The company reported EPS of -$0.01, while revenue was $0.04 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Glucose Health EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Glucose Health Revenue Results

Actual Revenue
$0.04 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Glucose Health Q2 2026 Earnings FAQ

Glucose Health (OTCMKTS:GLUC) reported earnings of -$0.01 per share for Q2 2026. The report was announced on Friday, August 14, 2026.

Glucose Health reported revenue of $0.04 million for Q2 2026.

Glucose Health Earnings Headlines

8 teas that can help lower blood sugar
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
See More Glucose Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Glucose Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Glucose Health and other key companies, straight to your email.

About Glucose Health

Glucose Health (OTCMKTS:GLUC) is a consumer health company focused on developing and marketing nutritional products intended to support healthy blood glucose levels and metabolic wellness. The company’s offerings are positioned as dietary supplements and functional nutrition products rather than prescription medicines.

Its principal product has been GlucoDown, a powdered drink mix marketed for use as part of a daily wellness routine. The product is formulated with nutritional ingredients intended to support blood sugar management, and is sold directly to consumers through online channels.

Publicly available information about Glucose Health’s operating history, geographic reach, and current leadership is limited. The company’s business has primarily been associated with the development, promotion, and sale of its branded glucose-support products.

View Glucose Health Profile